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LIQUID-LIQUID PHASE 
SEPARATION (LLPS)
LLPS is a physicochemical process where a 
liquid forms two phases: a condensed phase 
and a diluted phase.
MUTATION DATABASE GENERATION
1. LLPS Protein Consensus
2. Disease Mutation Database Selection + Filtering
CONCLUSIONS
We were able to compile a database of disease
mutations occurring in LLPS genes and
characterize them through several systematic
analyses. So far, we have observed that
mutations in LLPS genes are more likely to
increase the hydrophobicity of its proteins and to
occur in IDRs and PLDs.
Overall, we have promising data and findings for
constructing a detailed profile for our disease
mutations in LLPS genes. This profiling will help
us characterize and understand the roles of
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Filter for LLPS genes
Control = Non-LLPS genes LLPS 
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Ø Mutations in Protein Domains
Ø Stability & Protein Folding
q Protein-Protein Interactions
Ø PPI Networks
Ø Clients: Proteins involved in LLPS




Wild Type Protein 
(FASTA) sequences
K E A V D
108,670 Mutations in 
1,400 LLPS proteins
4,215 Mutations in 
278 LLPS proteins
Mutations in LLPS Proteins
Mutations that alter physicochemical properties 
of a protein can impact its probability of forming 




Fig 2. Mutations can cause LLPS proteins to form condensates (Gain-
of-Function/GOF, top half) or disrupt already formed protein







Fig 1. Through several forms of molecular interactions (1-4), LLPS
leads to a diluted (dark red) and condensed phase (light red) also










Fig 4. Disease associations recorded in HGMD that are significantly

































Significantly Enriched LLPS Genes
Fig 5. Percent of mutations in each database
that increased hydrophobicity of the protein
as measured with amino acid hydrophobicity








Protein Properties that cause LLPS
1. Hydrophobic & Electrostatic Interactions
2. Intrinsically Disordered Regions (IDRs)
3. Prion-Like Domains (PLDs)
4. Multiple Domains
5. Higher Expression
Fig 3. Methodology of obtaining disease-related missense mutation data related
to LLPS and its respective protein sequences for further structural and









Fig 6. When the SHP2/PTPN11 protein is
mutated (R362E), there is a change of
charge in the area of mutation. PDB: 4DGP
Fig 7. Mutations occurring in disordered
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4. Change in Expression
Fig 9. If data was available by Bayrak et al.
(2021), mutations were labeled as GOF or
LOF with regards to gene expression.
Fig 8. The PLDs of each mutated
protein sequence in HGMD were
predicted using PLAAC.
Mutations significantly occur in 
a PLD for LLPS genes in 
HGMD. (p = 5.4978e-18)
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